日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dominant clones leverage developmental epigenomic states to drive ependymoma

优势克隆利用发育表观基因组状态驱动室管膜瘤

Kardian, Alisha S; Sun, Hua; Ippagunta, Siri; Laboe, Nicholas; Varadharajan, Srinidhi; Yu, Kwanha; Chen, Hsiao-Chi; Emanus, Erik; Zheng, Tuyu; Deneen, Riley M; Connelly, Jon P; Wang, Yong-Dong; Zhan, Jiangshan; Liu, Hengxi; Lowe, Kimberley; Bugbee, Taylor; Pathak, Rakesh; Bland, Amanda; Mehta, Sanya; Cochiolo, Sophie; Arabzade, Amir; Holcomb, Blake; Budd, Kaitlin M; Kembuan, Gabriele; Wright, Tristen; Caesar, Emma; Park, Maxwell; Hancock, Amelia; Gee, David; Murdoch, Joel; Xiao, Yi; McBrayer, Samuel K; Merchant, Thomas E; Qi, Jun; Durbin, Adam D; Schwarz, Lindsay A; Wang, Li; Donson, Andrew M; Foreman, Nicholas K; Agnihotri, Sameer; Lavado, Alfonso; Baker, Suzanne J; Ellison, David W; Lee, Hyun Kyoung; Pruett-Miller, Shondra M; Bertrand, Kelsey C; Deneen, Benjamin; Mack, Stephen C

The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells

依赖于环境的表观遗传和器官发生程序决定了MYC驱动的小鼠肝癌细胞的3D与2D细胞适应性。

Fang, Jie; Singh, Shivendra; Wells, Brennan; Wu, Qiong; Jin, Hongjian; Janke, Laura J; Wan, Shibiao; Steele, Jacob A; Connelly, Jon P; Murphy, Andrew J; Wang, Ruoning; Davidoff, Andrew; Ashcroft, Margaret; Pruett-Miller, Shondra M; Yang, Jun

Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors.

儿童髓母细胞瘤中的黑色素瘤抗原导致肿瘤异质性和第 3 组肿瘤的物种特异性

Collins Rebecca R J, Florke Gee Rebecca R, Tozandehjani Sima, Bayat Tara, Hoyos Sanchez Maria Camila, Gutierrez Juan Sebastian Solano, Breznik Barbara, Lee Anna K, Peters Samuel T, Connelly Jon P, Pruett-Miller Shondra M, Roussel Martine F, Rakheja Dinesh, Tillman Heather S, Potts Patrick Ryan, Fon Tacer Klementina

Rapid and robust validation of pooled CRISPR knockout screens using CelFi.

使用 CelFi 对混合 CRISPR 基因敲除筛选进行快速、稳健的验证

Loughran Allister J, Narina Shilpa, Klein Jonathon, Siwak Jamaica F, Connelly Jon P, Pruett-Miller Shondra M

Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers

改造人类多能干细胞系以规避异种移植障碍

Pizzato, Hannah A; Alonso-Guallart, Paula; Woods, James; Johannesson, Bjarki; Connelly, Jon P; Fehniger, Todd A; Atkinson, John P; Pruett-Miller, Shondra M; Monsma, Frederick J Jr; Bhattacharya, Deepta

RBM39 degrader invigorates natural killer cells to eradicate neuroblastoma despite cancer cell plasticity

RBM39降解剂可激活自然杀伤细胞,从而根除神经母细胞瘤,即使癌细胞具有可塑性

Singh, Shivendra; Fang, Jie; Jin, Hongjian; Van de Velde, Lee-Ann; Wu, Qiong; Cortes, Andrew; Morton, Christopher L; Woolard, Mary A; Quarni, Waise; Steele, Jacob A; Connelly, Jon P; He, Liusheng; Thorne, Rebecca; Turner, Gregory; Confer, Thomas; Johnson, Melissa; Caufield, William V; Freeman, Burgess B; Lockey, Timothy; Pruett-Miller, Shondra M; Wang, Ruoning; Davidoff, Andrew M; Thomas, Paul G; Yang, Jun

Dominant Malignant Clones Leverage Lineage Restricted Epigenomic Programs to Drive Ependymoma Development

优势恶性克隆利用谱系限制性表观基因组程序驱动室管膜瘤发展

Kardian, Alisha; Sun, Hua; Ippagunta, Siri; Laboe, Nicholas; Chen, Hsiao-Chi; Emanus, Erik; Varadharajan, Srinidhi; Zheng, Tuyu; Holcomb, Blake; Connelly, Patrick; Connelly, Jon P; Wang, Michael; Lowe, Kimberley; Pruett-Miller, Shondra M; Bertrand, Kelsey C; Deneen, Benjamin; Mack, Stephen C

Spatially Resolved in vivo CRISPR Screen Sequencing via Perturb-DBiT.

通过 Perturb-DBiT 实现空间分辨的体内 CRISPR 筛选测序

Baysoy Alev, Tian Xiaolong, Zhang Feifei, Renauer Paul, Bai Zhiliang, Shi Hao, Li Haikuo, Tao Bo, Yang Mingyu, Enninful Archibald, Gao Fu, Wang Guangchuan, Zhang Wanqiu, Tran Thao, Patterson Nathan Heath, Bao Shuozhen, Dong Chuanpeng, Xin Shan, Zhong Mei, Rankin Sherri, Guy Cliff, Wang Yan, Connelly Jon P, Pruett-Miller Shondra M, Chi Hongbo, Chen Sidi, Fan Rong

High-Throughput Analysis of CRISPR-Cas9 Editing Outcomes in Cell and Animal Models Using CRIS.py

利用 CRIS.py 对细胞和动物模型中 CRISPR-Cas9 编辑结果进行高通量分析

Narina, Shilpa; Connelly, Jon P; Pruett-Miller, Shondra M

XAF1 as a modifier of p53 function and cancer susceptibility

XAF1作为p53功能和癌症易感性的调节因子

Pinto, Emilia M; Figueiredo, Bonald C; Chen, Wenan; Galvao, Henrique C R; Formiga, Maria Nirvana; Fragoso, Maria Candida B V; Ashton-Prolla, Patricia; Ribeiro, Enilze M S F; Felix, Gabriela; Costa, Tatiana E B; Savage, Sharon A; Yeager, Meredith; Palmero, Edenir I; Volc, Sahlua; Salvador, Hector; Fuster-Soler, Jose Luis; Lavarino, Cinzia; Chantada, Guillermo; Vaur, Dominique; Odone-Filho, Vicente; Brugières, Laurence; Else, Tobias; Stoffel, Elena M; Maxwell, Kara N; Achatz, Maria Isabel; Kowalski, Luis; de Andrade, Kelvin C; Pappo, Alberto; Letouze, Eric; Latronico, Ana Claudia; Mendonca, Berenice B; Almeida, Madson Q; Brondani, Vania B; Bittar, Camila M; Soares, Emerson W S; Mathias, Carolina; Ramos, Cintia R N; Machado, Moara; Zhou, Weiyin; Jones, Kristine; Vogt, Aurelie; Klincha, Payal P; Santiago, Karina M; Komechen, Heloisa; Paraizo, Mariana M; Parise, Ivy Z S; Hamilton, Kayla V; Wang, Jinling; Rampersaud, Evadnie; Clay, Michael R; Murphy, Andrew J; Lalli, Enzo; Nichols, Kim E; Ribeiro, Raul C; Rodriguez-Galindo, Carlos; Korbonits, Marta; Zhang, Jinghui; Thomas, Mark G; Connelly, Jon P; Pruett-Miller, Shondra; Diekmann, Yoan; Neale, Geoffrey; Wu, Gang; Zambetti, Gerard P